IDEAYA Biosciences (IDYA) Income from Continuing Operations (2020 - 2025)
Historic Income from Continuing Operations for IDEAYA Biosciences (IDYA) over the last 6 years, with Q4 2025 value amounting to -$94.6 million.
- IDEAYA Biosciences' Income from Continuing Operations rose 3438.93% to -$94.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$197.1 million, marking a year-over-year increase of 3970.52%. This contributed to the annual value of -$159.3 million for FY2025, which is 5127.67% up from last year.
- According to the latest figures from Q4 2025, IDEAYA Biosciences' Income from Continuing Operations is -$94.6 million, which was up 3438.93% from $108.5 million recorded in Q3 2025.
- Over the past 5 years, IDEAYA Biosciences' Income from Continuing Operations peaked at $108.5 million during Q3 2025, and registered a low of -$144.1 million during Q4 2024.
- In the last 5 years, IDEAYA Biosciences' Income from Continuing Operations had a median value of -$26.4 million in 2022 and averaged -$31.1 million.
- In the last 5 years, IDEAYA Biosciences' Income from Continuing Operations tumbled by 517969.7% in 2023 and then surged by 26212.76% in 2025.
- Quarter analysis of 5 years shows IDEAYA Biosciences' Income from Continuing Operations stood at -$18.4 million in 2021, then crashed by 43.95% to -$26.4 million in 2022, then plummeted by 58.52% to -$41.9 million in 2023, then plummeted by 243.87% to -$144.1 million in 2024, then skyrocketed by 34.39% to -$94.6 million in 2025.
- Its Income from Continuing Operations was -$94.6 million in Q4 2025, compared to $108.5 million in Q3 2025 and -$144.1 million in Q4 2024.